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Abstract
Background: The λ Red recombineering technology has been used extensively in Escherichia coli
and Salmonella typhimurium for easy PCR-mediated generation of deletion mutants, but less so in
pathogenic species of E. coli such as EHEC and EPEC. Our early experiments with the use of λ Red
in EHEC and EPEC have led to sporadic results, leading to the present study to identify factors that
might improve the efficiency of Red recombineering in these pathogenic strains of E. coli.
Results: In this report, we have identified conditions that optimize the use of λ Red for
recombineering in EHEC and EPEC. Using plasmids that contain a Ptac-red-gam operon and a
temperature-sensitive origin of replication, we have generated multiple mutations (both marked
and unmarked) in known virulence genes. In addition, we have easily deleted five O157-specific
islands (O-islands) of EHEC suspected of containing virulence factors. We have examined the use
of both PCR-generated substrates (40 bp of flanking homology) and plasmid-derived substrates (~1
kb of flanking homology); both work well and each have their own advantages. The establishment
of the hyper-rec phenotype requires only a 20 minute IPTG induction period of red and gam. This
recombinogenic window is important as constitutive expression of red and gam induces a 10-fold
increase in spontaneous resistance to rifampicin. Other factors such as the orientation of the drug
marker in recombination substrates and heat shock effects also play roles in the success of Red-
mediated recombination in EHEC and EPEC.
Conclusions: The λ Red recombineering technology has been optimized for use in pathogenic
species of E. coli, namely EHEC and EPEC. As demonstration of this technology, five O-islands of
EHEC were easily and precisely deleted from the chromosome by electroporation with PCR-
generated substrates containing drug markers flanked with 40 bp of target DNA. These results
should encourage the use of λ Red recombineering in these and other strains of pathogenic bacteria
for faster identification of virulence factors and the speedy generation of bacterial mutants for
vaccine development.
Background
A new method for engineering bacterial chromosomes
has emerged in recent years that takes advantage of the
high proficiency of bacteriophage recombination systems
acting on linear DNA substrates [see reference [1] for
review]. The λ Red recombination system, consisting of
Bet (a ssDNA annealing protein) and Exo (a 5'-3' dsDNA
exonuclease) promotes gene replacement of
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electroporated linear DNA substrates into the Escherichia
coli K-12 chromosome at a very high efficiency [2-5]. Inac-
tivation of host RecBCD exonuclease activity, either by
mutation or production of the anti-RecBCD Gam func-
tion, is required for efficient Red-promoted recombina-
tion with linear dsDNA substrates [2]. Zhang and co-
workers [6], using the E. coli rac prophage RecET recombi-
nation system, recognized that PCR-generated substrates
with as little as 40 bp of homology could serve as efficient
substrates for gene replacement in E. coli. The use of such
substrates has also been demonstrated with the λ Red sys-
tem, with Red and Gam being supplied from either a
prophage [4], a low-copy number plasmid [5], or from a
∆recBCD::Ptac-gam-red chromosomal substitution [unpub-
lished observations]. The high efficiency of Red and
RecET-promoted recombination with such short regions
of homology has allowed E. coli geneticists to perform
oligo-directed gene replacements that yeast geneticists
have performed for years [7-9].
The establishment of a hyper-recombinogenic phenotype
in E. coli K-12 by expression of plasmid-encoded Red and
Gam in vivo suggested that the system might easily be
adapted for use in other bacterial strains. In fact, many
labs have reported the use of λ Red for making PCR-gen-
erated gene knock-outs in Salmonella enterica Serovar
typhimurium [10-16] and Salmonella enterica Serovar
enteritidis [17]. λ Red has also been used for epitope tag-
ging of chromosomal genes in Salmonella enterica [18].
Day and co-workers have used λ Red for generating a
dsbD::ery substitution in Shigella flexneri [19]. Recently,
Derbise et al [20] have used Red to promote gene replace-
ment in Yersinia pseudotuberculosis, though the efficiency
with PCR substrates containing short regions of homol-
ogy was successful for only one out of three loci tested.
Pathogenic E. coli species should also be amenable to the
use of λ Red for chromosomal engineering. Enterohemor-
rhagic E. coli O157:H7 (EHEC) and enteropathogenic E.
coli (EPEC) are members of the attaching and effacing
(AE) family of enteric pathogens [21,22]. These pathogens
bind tightly to the intestinal epithelium and cause local-
ized effacement of micovilli, followed by alteration of the
cytoskeleton beneath sites of bacterial attachment. Some
labs have used λ Red to promote gene knockouts in EPEC
by recombination between linear plasmid DNA fragments
containing long regions of homology (~0.5 – 1 kb) and
the EPEC chromosome [23-25]. In addition, a few reports
have utilized PCR substrates containing short regions of
homology to perform gene replacement in EHEC [26-28],
the latter report employing plasmids and protocols
described herein. None of these reports, however,
described the frequency of recombinant formation or the
reproducibility of Red-promoted PCR-mediated recombi-
nation in EHEC at multiple loci. Indeed, our initial
attempts to employ λ Red for PCR-mediated gene replace-
ment at various loci in EHEC in EPEC were met with spo-
radic success, similar to the limited success seen with Red-
promoted short homology recombination in Y. pseudotu-
berculosis. These difficulties prompted us to examine more
closely the methodologies of λ Red promoted PCR-medi-
ated gene replacement, especially in regard to optimizing
its use in EHEC and EPEC.
In this report, we have found conditions that allowed us
to reproducibly obtain PCR-mediated recombinants using
λ Red recombination in EHEC and EPEC, guidelines that
might also apply to the use of Red in other pathogenic
bacteria. These steps include the use of an optimal buffer
for the preparation of electrocompetent cells, a heat-shock
step that induces higher frequencies of gene replacement,
and proper positioning of the drug marker within the
recombinant PCR substrate. As demonstration of the util-
ity of this technology, five EHEC O-islands were easily
deleted from the EHEC chromosome by simple electropo-
ration with PCR-generated substrates. We also have noted
the importance of limiting expression of Red functions
during growth of EHEC, as extended expression of the
recombination functions induces a 10-fold increase in
spontaneous mutagenesis. Finally, we report gene replace-
ment frequencies generated by various treatments of plas-
mid substrates to construct marked and precise deletions
of EHEC eae, tir, and the eae-cesT-tir operon.
Results
λ Red for PCR-mediated gene replacement in EHEC
Red-promoted gene replacement using PCR derived sub-
strates is diagrammed in Figure 1. Typically, PCR is per-
formed with two primers (60 mers) which contain 20
bases at the 3' ends to amplify a drug marker. In addition,
the primers contain 40 bases at the 5' ends that are com-
plimentary to either the upstream or downstream regions
of the target gene (see Figure 1). The PCR product, which
has the drug marker flanked by 40 bases upstream and
downstream of the targeted gene of interest, is simply elec-
troporated into Red + Gam producing E. coli or Salmonella.
This strategy has been shown to promote high efficiency
gene replacement with such substrates in E. coli K-12 [4,5],
as well as Salmonella species (see Background).
We have previously shown that a Red + Gam-producing
plasmid (pTP223) promotes gene replacement efficiently
with substrates containing long regions of homology to
the target gene [2,3]. On the other hand, PCR substrates
containing short regions of homology (40–60 bp) recom-
bine at very low frequency when Red and Gam are sup-
plied by multi-copy plasmid pTP223 [reference [5];
unpublished observations]. We and others have noted
that expression of red from the chromosome (or low copy
number plasmids) is better suited for Red-promoted
λ
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recombination [2,4,5]. It is assumed that since Red
induces the rolling circle mode of replication in medium
or high copy number plasmids [29], linear multimers of
the plasmid are generated that may compete with the elec-
troporated substrates for the Red recombination func-
tions. This reasoning explains why pTP223, while
expressing high levels of Red and Gam, is not optimal for
Red-promoted gene replacement in E. coli K-12. In addi-
tion, studies in our lab with ∆recBCD::gam-red chromo-
somal substitutions (i.e., no resident plasmid), expressing
red from either Plac or the stronger Ptac promoter, have
shown that Red-promoted recombination with short-
homology substrates requires higher level expression of
the red functions relative to long-homology substrates
[unpublished observations]. This observation explains
why pTP223 works well with long homology substrates,
but not well with short homology substrates: the limited
amount of "free" Red functions when expressed from
pTP223 is adequate for long homology substrates, but not
for PCR (short homology) substrates.
A construct that meets both these requirements (high
expression from a single or low copy number replisome)
is plasmid pKD46, described by Datsenko and Wanner [5]
which uses the pBAD promoter to express red and gam
from a low copy number temperature-sensitive replicon.
A similar plasmid was constructed in our lab, except that
gam and red are driven by the Ptac promoter (pKM201). A
variation of pKM201 was constructed which expresses the
lacI repressor gene (pKM208) in order to keep expression
of red and gam under tight control prior to IPTG induc-
tion. In anticipation of the requirement to easily remove
these plasmids after gene replacement, both plasmids
contain temperature-sensitive origins of replication.
EHEC containing pTP223, pKM201, or pKM208 were
electroporated with a PCR substrate containing the kan
gene flanked by 40 bases from the 5' and 3' regions of the
lacZ gene, using an optimized protocol scheme for prepa-
ration of electrocompetence cells as described in the
Methods section. Recombinants were detected as white
KanR colonies on LB-kan plates containing X-gal and
IPTG, as previously described [2]. As expected, plasmid
pTP223 was unable to efficiently promote short-homol-
ogy recombination in EHEC (data not shown; however,
see results with EPEC below). On the contrary, low copy
number plasmids pKM201 and pKM208 were able to pro-
mote short homology recombination in EHEC at the lacZ
locus. Cells harboring LacI-expressing pKM208 required
prior induction with IPTG for efficient recombination (see
below); cells containing pKM201 did not require IPTG
addition (due to Ptac leakiness in the absence of over-
expressed LacI). In five separate experiments, Red expres-
sion from pKM208 produced gene replacements at a rate
between 70–600 recombinants per 108 cell survivor (total
number of recombinants varied from 750–3000). From
one of these experiments, ten out of ten white KanR trans-
formants tested positive for gene replacement by PCR
analysis (data not shown). In addition, a PCR fragment
containing a lacZ deletion with a cat insertion worked as
well as the one described above using kan. It is notewor-
thy, however, that while the ∆lacZ::kan allele yielded
recombinants at a frequency of 0.7–6 × 10-6 per survivor
in EHEC containing pKM208, the same PCR fragment in
E. coli K-12 containing pKM208 yielded recombinants at
a frequency of 10-4 per survivor (data not shown). The
sequences used in targeting ∆lacZ to the E. coli K-12 and
EHEC chromosomes are identical. The reason for this
lower frequency is not known, but may be due to lower
expression of red and gam in EHEC, an EHEC-specific
restriction system(s), or lower rates of DNA uptake fol-
lowing electroporation.
One other possibility for the reduction in efficiency of Red
+ Gam-promoted PCR-mediated gene replacement in
EHEC relative to that seen in E. coli K-12 is that the λ Gam
Schematic of λ Red-promoted PCR-mediated recombinationFigure 1
Schematic of λ Red-promoted PCR-mediated recom-
bination. PCR products, containing a drug marker flanked 
by 40–60 bp of target DNA, are generated by primers desig-
nated 5KO and 3KO (see Table 6 in Additional file #2) and 
electroporated into EHEC containing pKM201 or pKM208 
(or EPEC containing pTP223). Chromosomal replacements 
were verified by PCR using primers upstream (U), down-
stream (D) and within the drug marker (M) (data not shown).
chromosome
Modified
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Red recombination
3KO 5KO
kan
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protein might not be as active on EHEC RecBCD as it is for
E. coli K-12 RecBCD. This seemed unlikely given the con-
servation of the recBCD genes between these two species
(97–98% conservation). Nonetheless, we made a EHEC ∆
recC::cat knockout and tested its ability to perform Red-
promoted PCR-mediated recombination. Deactivating
RecBCD function by deletion of recC did not stimulate λ
Red recombination in EHEC at the lacZ locus (data not
shown). Thus, to a first approximation, λ Gam works as
efficiently with EHEC RecBCD as it does with E. coli K-12
RecBCD. Another possibility is that the red functions from
the endogenous lambdoid EHEC prophage 933 W would
be better suited than λ red for gene replacement in EHEC.
This seems unlikely given the high degree of conservation
between λ and 933 W red genes (99.6% identity), and was
not tested.
Gene replacements using short homology substrates were
also performed in EHEC containing pKM201 at the tir and
espF loci within the locus of enterocyte effacement (LEE),
though frequencies of gene replacement at these sites (in
repeated experiments) were lower than that seen with the
lacZ substrate described above, and usually ranged from
0–20 recombinants per 108 survivor. However, this lower
frequency of gene replacement at alternative loci relative
to lacZ was also observed in E. coli K-12 [unpublished
observations]. Thus, the lacZ region may be a hotspot for
gene replacement, perhaps the result of stable expression
of the drug marker following integration at this particular
locus (see below). Nonetheless, Red-promoted PCR-
mediated gene replacement was successful with both tir
and espF.
To assess the overall usefulness of Red-promoted PCR-
mediated gene replacement in EHEC, we targeted five
O157-specific islands (O-islands) in the EHEC chromo-
some for deletion; these O-islands are not present in E. coli
K-12 [30]. PCR substrates containing the kan gene flanked
by 40 base pairs of DNA bordering O-islands #12, #77,
#103, #130–131 and #169 (Table 1) were electroporated
into EHEC containing pKM208. These islands were tar-
geted because they occupy different regions of the
chromosome, are of moderate size (733–4253 base pairs
in length), and encode either putative virulence factors or
unknown proteins. In the first attempt, all five islands
were successfully deleted (see Table 1), though there was
variability in the frequency of island replacement. Dele-
tion of O-islands #130–131 (one replacement) occurred
at a frequency similar to that seen with lacZ gene (~100
KanR transformants per 108 cell survivors), while the oth-
ers showed rates ranging from 10–50 fold lower. Thus, λ
Red is able to promote efficient short homology recombi-
nation with the EHEC chromosome, but with variability
according to the target site.
To determine if any restrictions could be placed on the
amount of DNA deleted by Red-promoted recombina-
tion, we generated a PCR product containing the cat gene
flanked by regions upstream and downstream of an
internal section of O-island #148, which contains the
locus of enterocyte effacement (LEE). Electroporation
with this PCR fragment, designed to delete 9 kb of genes
encoding the type III secretion apparatus (see Table 4,
strain KC30) generated recombinants at a relatively low
frequency of 20 per 108 survivors, similar to the deletion
frequencies seen with island #169 above. Thus, both
small and large regions of the EHEC chromosome can be
deleted in one step using Red-mediated recombination
(as has been seen with E. coli K-12). Indeed, an additional
15 islands of EHEC of various sizes up to 45 kb have sub-
sequently been deleted in EHEC by Red-promoted PCR-
Table 1: λ Red-promoted PCR-mediated replacement of five targeted EHEC O-islandsa
Targeted Island Sequence numbersb Gene(s) putative functions # of colonies c(half the 
culture)
Growth on kanamycin d(# 
KanR/# streaked)
PCR analysis (# verified/# 
tested)
O-island #12 353934 – 358187 eaeH putative adhesin 10 8/10 3/3
O-island #77 2710424 – 2712382 Z3025 unknown function 37 10/10 4/6
O-island #103 3315828 – 3317575 Z3664 putative virulence protein 18 18/18 2/3
O-island #130–131 4255687 – 4256420 hopD putative enzyme; 
degradation
254 18/20 3/3
Z4695 putative iron storage
yheA unknown function
O-island #169 5311698 – 5313445 Z5815 putative transposase 5 5/5 2/5
Z5816 putative virulence protein
a) O157::H7 genetic elements not present in E. coli K-12 b) Genbank accession number AE005174 [30]. c) An estimated 0.25 µg of DNA (3.5 µl) 
was mixed with 50 µl of electrocompetent EHEC cells and shocked as described in Methods section. Cells were suspended in 3 ml LB following 
electroporation and grown at 37° for 90 min. Half the culture (1.5 ml) was concentrated by centrifugation and spread on LB plates containing 20 µg/
ml kanamycin. In the same experiment, a PCR fragment containing the ∆lacZ::kan allele generated 272 KanR transformants. d) Following 24 h 
growth, candidates were restreaked on LB-kan plates. Among these KanR candidates, recombinant deletion formation was verified by PCR analysis 
as described in Methods section (data not show).
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mediated island replacement using pKM201 [Campellone
and Leong, unpublished].
Drug marker context dependency affects the efficiency of 
gene replacement
EHEC strains containing the kan substitutions shown in
Table 1 were further purified by streaking on LB plates
containing 40 µg/ml kanamycin. Interestingly, kan substi-
tuted islands #12, #77 and #169, while selected on LB
plates containing kanamycin at 20 µg/ml, did not grow at
this higher kanamycin concentration (but did restreak
well at 20 µg/ml). The other two substitutions (∆island
#103::kan and ∆islands #130–131::kan), which consist-
ently gave higher frequencies of gene replacement relative
to the others, grew well on LB containing 40 µg/ml kan-
amycin. These results suggest that the position and/or ori-
entation of the drug cassette within the chromosome
alters its expression levels. Thus, the low frequency of O-
island #169 replacement (see Table 1) might be due to the
influence of neighboring transcripts reading into the kan
gene following integration of the ∆island 169::kan PCR
substrate into the chromosome, or instability of the kan
transcript due to sequences fused to its 3' end. To test this
hypothesis, deletion of O-island #169 was repeated using
a PCR product that reversed the direction of kan transcrip-
tion within this chromosomal region. This PCR product
was generated with primers ∆island169E & ∆island169F;
see Table 6 (Additional file #2). In three separate experi-
ments, we found (on average) 10-fold higher KanR trans-
formants when kan was reading leftward from the
position of O-island #169 (according to the numbering in
the sequence file) instead of rightward. This leftward read-
ing direction of the kan gene places it colinear with other
genes in this region (ytfB and Z5814) and supports the
notion that proper positioning of the drug marker in the
chromosome can influence the recovery of the
recombinant.
Extended expression of Red and Gam is mutagenic
Unlike E. coli K-12 and Salmonella enterica Serovar Typh-
imurium, there are no phage transductional protocols for
EHEC to place λ Red-generated deletion alleles into clean
genetic backgrounds. Thus, it was important to consider
the possible mutagenic profile of λ Red expression in
EHEC. Somewhat surprisingly, overnight cultures of
EHEC containing uncontrolled expression of red and gam
from pKM201 (which does not express lacI) showed a 10-
fold increase in the rate of spontaneous rifampicin resist-
ance (Figure 2). EHEC containing pKM208 (which
expresses the lacI repressor as well as the Ptac-red-gam
operon) showed a significant increase in rifampicin resist-
ance only when incubated in the presence of IPTG
overnight.
In order to determine the minimum time of Red induc-
tion required to generate the hyper-rec phenotype, we
measured the frequency of gene replacement as a function
of IPTG induction. Figure 3 shows that a 20 minute expo-
sure to IPTG is sufficient to induce the hyper-rec pheno-
type in EHEC. For most of the experiments reported
above, we used a 1 hour IPTG induction period. Thus, we
examined if Red induction for 1 hour induced a muta-
genic phenotype in EHEC. EHEC cells containing
pKM208 were exposed to IPTG for 1 hour in a manner
identical that used for the preparation of electrocompe-
tent cells, and plated on LB plates containing rifampicin.
No increase in RifR cells was seen in such preparations
when compared to uninduced cultures (see Figure 3,
insert). Thus, while uncontrolled expression of red and
gam causes a 10-fold increase in mutagenesis, limited
expression of red and gam required for establishment of
the hyper-rec phenotype is not mutagenic, at least with
regard to the generation of rifampicin resistant mutants.
λ Red-promoted PCR-mediated recombination in EPEC
Red and Gam-producing plasmid pKD46 has been
reported for use in long homology recombination of plas-
mids with the EPEC chromosome, but not short homol-
ogy PCR-mediated recombination. We decided to test our
plasmids in EPEC for Red-promoted PCR-mediated
recombination. Despite repeated attempts, we were not
able to transform EPEC with either of the pSC101-origin
containing plasmids pKM201 or pKM208. We, as yet, do
not know the reason for this result. However, we were able
to electroporate EPEC with pTP223. Surprisingly, and
unlike the case with EHEC, pTP223 did promote efficient
short homology recombination with PCR substrates. We
have used this plasmid to construct an EPEC∆tir construct
(the details of the construction of this strain have been
described previously [23]). We have also constructed a 13
kb deletion within the locus of enterocyte effacement in
EPEC (KC21) in a manner similar to that described above
for EHEC (described in Table 4), with the exception that
pTP223 was used to supply  Red and Gam. Also, we find
that the heat shock step plays a stimulatory role in Red-
promoted PCR-mediated EPEC gene replacement. In one
set of experiments, the heat shock step with EPEC resulted
in 2–10 fold increase in the number of recombinants
(corresponding to a 20–100 fold increase in frequency of
recombinants per survivor of electroporation). The effect
of the heat shock step is quite variable, however, as we
found the stimulation of recombinants per survivor using
the ∆lac::kan allele in EHEC to be only 2–4 fold.
Long homology recombination (LHR) substrates with 1–2 
kb of flanking DNA
While λ Red-promoted recombination with PCR-gener-
ated substrates offers the simplest mechanism for generat-
ing gene knockouts, there are other times when using long
λ
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Uncontrolled λ Red expression is mutagenicFigure 2
Uncontrolled λ Red expression is mutagenic. A single fresh colony of EHEC strain TUV93-0 (with indicated plasmids) 
was suspended in 1 ml LB containing 100 µg/ml ampicillin. The cell suspension was diluted with LB-ampicillin to a final concen-
tration of 5 × 104 cells/ml and aliquoted to 24 culture tubes. Overnight cultures (0.3 ml each) of EHEC with control plasmid 
(circles), pKM201 (squares), pKM208 (triangles) and pKM208 with IPTG added (diamonds) were plated on LB plates containing 
100 µg/ml rifampicin. Plates were incubated overnight at 37 degrees and rifampicin resistant colonies were counted 24 hours 
later. Average number of RifR colonies (with standard errors) for each culture are as follows: control plasmid, 14.1 (2.7); 
pKM201, 173 (33.3); pKM208, 40.4 (9.9); pKM208 + IPTG, 194 (21.9).
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Time course for promotion of hyper-rec phenotypeF gure 3
Time course for promotion of hyper-rec phenotype. EHEC strain TUV93-0 containing pKM208 (five cultures, 20 ml 
each) was grown for electrocompetence as described in the Methods section. At various times prior to collection, IPTG was 
added to four of the cultures to a final concentration of 1 mM; the fifth culture received no IPTG. The cells were heat shocked 
for the final 15 minutes, prepared for electroporation and electroporated with DNA (~0.25 µg) containing the kan gene 
flanked by 40 bp of EHEC DNA (resulting in a deletion of O-islands #130 and #131). After suspension in LB, the cells were 
grown for 90 minutes at 37°C and plated on LB plates containing 20 µg/ml kanamycin. The number of KanR transformants per 
108 survivor and total number of KanR transformants are plotted as a function of IPTG concentration. The data points are aver-
ages of two experiments (ranges are shown). A random check of 160 colonies showed that 95% re-struck successfully to fresh 
LB plates containing 20 µg/ml kanamycin; 10 of 10 of these colonies were verified by PCR analysis to be true recombinants 
(data not shown). Insert: 0.1 ml of electrocompetent cells, prepared with and without 1 hour IPTG induction, were spread on 
LB plates containing 100 µg/ml rifampicin to determine total number of RifR mutants. Dilutions of the cells were titered on LB 
plates to determine total cell density; experiments done in triplicate (+/- standard error).
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homology-containing plasmid substrates are advanta-
geous. For instance, when multiple mutant alleles of a tar-
get gene need to be crossed into the chromosome, it is
desirable to have the substrate previously cloned, in order
to not induce PCR errors into the allele prior to transfer to
the chromosome. A dedicated plasmid containing
sequenced regions upstream and downstream regions of
the target gene is required. Also, long homology-contain-
ing substrates promote higher frequencies of gene
replacement relative to short homology substrates, and
offer higher success rates for Red-promoted gene replace-
ment in pathogenic hosts that are not as electrocompetent
as E. coli K-12. Thus, we examined a variety of plasmid-
derived substrates to test Red-promoted knockouts of eae,
tir and the tir-cesT-eae region in the EHEC chromosome.
The product of the eae gene, intimin, is an outer mem-
brane protein that is necessary for attachment to the target
cell. The receptor for intimin, Tir (translocated intimin
receptor), is a bacterial protein that is translocated into the
host cell membrane by the LEE-encoded type III secretion
system. cesT encodes a chaperone for Tir [see reference
[21] for review].
Plasmid substrates were constructed that contained the cat
gene (conferring resistance to chloramphenicol) flanked
by upstream and downstream regions of tir, eae, or the tir-
cesT-eae operon. Linear DNA recombination substrates
(i.e., the cat gene flanked by 1.5 kb of target DNA) were
generated from these plasmids by digestion with restric-
tion enzymes(see Tables 4 & 5 for details). EHEC cells
harboring pTP223 were electroporated with the restriction
digests, or gel-purified linear fragments containing the
marked deletions, and plated on LB plates containing
chloramphenicol. Among the chloramphenicol resistant
colonies, potential chromosomal substitutions were dis-
tinguished from simple plasmid transformants by their
sensitivity to ampicillin (bla gene carried within the
pUC19 plasmid backbone). Results of a number of these
experiments are shown in Table 2.
In all cases, ∆eae, ∆tir, or ∆eae-cesT-tir was easily generated
with these plasmid substrates, generating as few as 2 and
as many as 1000 gene replacements per experiment,
depending on the nature and amount of the transforming
DNA. These genes were replaced with either the cat drug
marker (Table 2, lines 1, 2, 4–9) or a cat-sacB cassette
Table 2: Gene replacements in the tir-cesT-eae region of enterohemorrhagic E. coli 0157:H7 using long homology-containing substrates
Exp # Substrate preparation Amount of DNA Genotype of 
linear fragment
Total Transformants Percent transformants 
Amp sensitive
Recombinants verified by 
PCR (# verified/# tested)
Plasmid digests:
1. restriction digest pKM184 (SacI, SphI) 2 µg ∆eae::cat >500 11% (4/35) 1/1
2. restriction digest pKM185 (SacI, SphI) 2 µg ∆eae-cesT-tir::cat 103 2.6% (2/76) 1/1
3. restriction digest pKM 187 (SacI, SphI) 1 µg ∆eae::cat sacB > 500 2.8% (1/35) 1/1
Plasmid digests including backbone:
4. restriction digest pKM184 (SacI, SphI, ApaLI) 0.5 µg ∆eae::cat 52 57% (4/7) NT
5. restriction digest pKM184 (SacI, SphI, ApaLI) 10 µg ∆eae::cat > 500 95% (143/151) 10/10
6. restriction digest pKM185 (SacI, SphI, ApaLI) 2 µg ∆eae-cesT-tir::cat 30 56% (9/16) 9/10
7. restriction digest pKM185 (SacI, SphI, ApaLI) 2 µg ∆eae-cesT-tir::cat 36 50% (9/18) 7/9
Gel-purified fragments:
8. purified SacI-SphI fragment from pKM185 0.5 µg ∆eae-cesT-tir::cat 225 100% (20/20) 1/1
9. purified KpnI fragment from pKC2 0.1 µg ∆tir::cat 6 NT 6/6
10. purified SacI-SphI fragment from pKM188 0.6 µg ∆eae cesT tir::cat 
sacB
273 100% (40/40) 1/1
11. purified KpnI fragment from pKC3 0.05 µg ∆tir::cat sacB 2 NT 2/2
Table 3: Generation of EHEC 0157:H7 unmarked deletions of eae and tir
Exp Substrate Preparation Amount of DNA Genotype of linear 
fragment
Genotype of 
recipient
Percent SucR 
CamStransformantsa
Recombinants verified by 
PCR (# verified/# tested)
1. Digest of pKM182 
(SacI, SphI)
2 µg ∆eae-cesT-tir ∆eae-cest-tir::cat-sacB 94% (94/100) 6/6
2. Digest of pKM181 
(SacI, SphI)
2 µg ∆eae ∆eae::cat-sacB 88% (88/100) 6/7
3. Purified KpnI 
fragment from pKC5
0.1 µg ∆tir ∆tir::cat-sacB 10.5% (2/19) 2/2
a) The selection for SucR-CamS transformants (containing precise in-frame deletions) was performed as described previously for E. coli K-12 [3].
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(Table 2, lines 3, 10 and 11). The latter substitutions gen-
erated strains that were subsequently used to generate in-
frame, precise deletions (see Table 3). Gene replacements
were verified by PCR analysis on all selected candidates
(1–6) in each experiment, using oligo primers within and
outside the regions of the linear DNA substrates (data not
shown). Overall, the following observations were evident:
Electroporation of simple plasmid digests resulted in a
high number of non recombinogenic plasmid transform-
ants (i.e., CamR-AmpR, see Table 2, lines 1–3), due to
incomplete digestion or religation of the plasmid sub-
strate in vivo. A higher number of potential gene replace-
ment transformants (i.e., CamR-AmpS colonies) could be
obtained by further digestion of the plasmid with a back-
bone-specific restriction enzyme, ApaLI (see Table 2, lines
4–7), or by gel purification of the linear DNA
recombination substrate (Table 2, lines 8–11). Interest-
ingly, the Red-producing plasmid pTP223 is
spontaneously lost during this process (between 10–50%
of the transformants are TetS). Thus, fortuitously, a sepa-
rate step to cure the recombinant of the Red plasmid is not
required. These experiments show that marked and pre-
cise deletions can be easily generated in EHEC without the
need to form and resolve plasmid co-integrates. We have
used this procedure recently to generate deletions at the
recC and dam loci in EHEC (experiments to be described
elsewhere).
The drug marker context effect seen above with construc-
tion of the ∆island #169 deletion using PCR substrates
was also seen with one of the long homology substrates.
Initial attempts to generate the EHEC chromosomal
replacement ∆eae::cat using SacI-SphI fragment from
pKM184 yielded no recombinants with repeated
attempts. The orientation of the cat gene inserted within
the eae flanking regions of pKM184 was determined, and
found to be reading opposite to the direction of the
endogenous eae gene. Thus, a version of pKM184 was con-
structed where the cat gene was inserted co-directionally
with eae. Electroporation with this substrate readily
yielded recombinants (see Table 2, lines 1, 4–5). Thus
again, we find that the orientation of the drug marker
within the target gene site can alter either its expression
level (preventing the selection of the recombinant) or its
ability to be stably incorporated into the chromosome.
With difficult substitutions, both orientations of the drug
marker (or the use of properly positioned transcription
terminators within the plasmid construct) should be
attempted. Context dependent marker expression may be
one of the primary causes of the variation seen among
Red-promoted gene replacements of the same drug
marker placed at different loci along the E. coli K-12 and
Salmonella enterica Serovar typhimurium chromosomes
[unpublished observations; S. Maloy, personal
communication].
Table 4: Strains used and constructed in this study
Strain Description Source or reference
EDL933 EHEC O157:H7 prototype [39]
TUV93-0 Stx-derivative of EDL933 A. Donohue-Rolfe
JPN15/pMAR7 AmpR derivative of EPEC E2348/69 
O127:H6 prototype
[40]
Derivatives of EHEC TUV93-0:
KM45 ∆tir-cesT-eae::cat TUV93-0/ pTP223 × SacI-SphI fragment from pKM185
KM46 ∆tir-cesT-eae::cat-sacB TUV93-0/ pTP223 × SacI-SphI fragment from pKM188
KM47 ∆eae::cat TUV93-0/ pTP223 × SacI-SphI fragment from pKM184
KM48 ∆eae::cat-sacB TUV93-0/ pTP223 × SacI-SphI fragment from pKM187
KM60 ∆eae KM48/ pTP223 × SacI-SphI fragment from pKM181
KM61 ∆tir-cesT-eae KM46/ pTP223 × SacI-SphI fragment from pKM182
KC2 ∆tir::cat TUV93-0/pTP223 × KpnI fragment from pKC2
KC3 ∆tir::cat-sacB TUV93-0/ pTP223 × KpnI fragment from pKC3
KC5 ∆tir KC3/ pTP223 × Kpn I fragment from pKC5
KC27 ∆tir::cat TUV93-0/pKM201 × PCR fragment (5KO-H-tir, 3KO-H-tir)
KC30 ∆LEE::cat TUV93-0/pKM201 × PCR fragment (5KO-H-LEE, 3KO-H-LEE)
KC40 ∆espF::cat TUV93-0/pKM201 × PCR fragment (5KO-H-espF, 3KO-H-espF)
KM90 ∆lacZ::cat TUV93-O/pKM201 × PCR fragment (cat13, cat14)
KM94 ∆lacZ::kan TUV93-O/pKM208 × PCR fragment (kan3, kan4)
KM95 ∆eaeH::kan TUV93-O/pKM208 × PCR fragment (5KO-H-Island 12, 3KO-H-Island 12)
KM96 ∆Z3025-Z3026::kan TUV93-O/pKM208 × PCR fragment (5KO-H-Island 77, 3KO-H-Island 77)
KM97 ∆Z3664::kan TUV93-O/pKM208 × PCR fragment (5KO-H-Island 103, 3KO-H-Island 103)
KM98 ∆hopD-Z4695-yheA::kan TUV93-O/pKM208 × PCR fragment (5KO-H-Island 130–131, 3KO-H-Island 130–131)
KM99 ∆Z58155-Z5816::kan TUV93-O/pKM208 × PCR fragment (5KO-H-Island 169, 3KO-H-Island 169)
Derivatives of EPEC JPN15/pMAR7
KC21 ∆LEE::cat JPN15/pMAR7/ pTP223 × PCR fragment (3KO-P-LEE, 5KO-P-LEE)
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Conclusion
The ability to inactivate or replace a gene of interest in the
chromosomes of bacterial pathogens is a critical step in
the identification of virulence factors, and in the elucida-
tion of mechanisms of infectivity. However, gene replace-
ment protocols for most pathogenic bacteria prove
difficult and time consuming. The success of the λ Red
bacteriophage recombination system to promote gene
replacement in E. coli K-12 and Salmonella enterica Serovar
Typhimurium suggested that this system should work well
in pathogenic species of E. coli. We have shown here that
λ Red can be efficiently utilized for the manipulation of
the chromosomes of EHEC and EPEC. Using protocols
described here, we have found that five out of five O-
islands in EHEC were successfully knocked-out and
replaced with the kanamycin resistance gene.
The versatility of the Red system in EHEC is highlighted
here by the range of chromosomal segments that can be
deleted; Red deleted pathogenicity islands as small as 733
bp and as large as 45 kb. In addition, the Red-producing
plasmids described here, (including pTP223 which does
not have a temperature sensitive origin of replication) are
unstable following induction with IPTG (10–50% of the
transformants lose the plasmid). This is rather a fortuitous
result, as gene replacement and plasmid curing occurs
simultaneously after electroporation, and such transform-
ants can be found by screening. Transformants cured of
the plasmid and modified at the gene of interest are read-
ily available for in vitro and in vivo analyses.
We found that λ Red and Gam work less efficiently in
EHEC relative to E. coli K-12 (as judged by recombination
in the lacZ locus). Despite this lower frequency, λ Red
works at an efficiency that appears to allow any non-
essential regions of the chromosome to be manipulated.
This is true for EPEC as well when red and gam are
expressed from plasmid pTP223. It is curious that pTP223
works well in EPEC, but not in EHEC or E. coli K-12 for
PCR-mediated Red recombination. Perhaps in EPEC,
pTP223 does not replicate by extensive rolling-circle rep-
lication as was seen for E. coli K-12, thus preventing linear
multimers of the plasmid from interfering with Red func-
tion. This hypothesis, however, has not been tested.
Another interesting observation reported here is the muta-
genic phenotype of constitutive red overexpression. One
possibility for this effect could be that the annealing func-
tion of Bet interferes with mismatch repair pathway of E.
coli by reannealing the unwound ssDNA generated by
UvrD, thus interfering with the progression of the mis-
match repair process. The mutagenic phenotype of consti-
tutive Red expression (and possibly RecET as well)
highlights the importance of controlling these functions
in vivo when using them for gene replacement in patho-
genic bacteria (i.e., limiting their expression to a recombi-
nogenic window). The mutagenesis associated with Red
may explain why many bacterial species don't possess a
constitutive phage-like recombination system as their pri-
mary recombination pathway, and instead employ the
more discriminating Chi-activated RecBCD dsDNA exo-
nuclease to generate recombinant intermediates (a path-
way that doesn't involve a known Bet-like ssDNA
annealing protein).
The plasmids and procedures described here have recently
been used to make gene replacements in enteroaggrega-
tive E. coli, using both long and short homology substrates
(Edward Dudley, personal communication). We are cur-
rently attempting to adapt the λ Red recombination
system for use in Pseudomonas aeruginosa, and other bacte-
rial pathogens. Though not yet verified, EHEC and EPEC
containing Red and Gam-producing plasmids may also be
amenable to ssDNA oligo-directed chromosomal altera-
tions and in vivo cloning by gap repair, as has been dem-
onstrated with E. coli K-12 strains expressing phage
recombination functions [31-33]. Clearly, if the chromo-
somes of pathogenic organisms could be manipulated
with the ease with which we now do gene replacement in
E. coli, it would be a dramatic development for the analy-
sis of bacterial pathogenic mechanisms. This is especially
true now that genomes of clinically relevant bacteria are
being sequenced, and thousands of new genes are at our
disposal for genetic analysis.
Methods
Strains and Plasmids
Strains used and generated in this study are listed in Table
4. The strain KC5 (EHEC∆tir) has been previously cited
[23]; its construction is described here. Plasmids pKM154,
pTP550, pTP223, pTP806, and pTP826 have been previ-
ously described [3,34-36]. pAMPts (5.2 kb), an ampicillin
derivative of pMAK705 [37], was constructed by Greg
Phillips (Iowa State University) and was a gift from Paul
Danese (Harvard). A CamR version of pKM201 (pKM200)
was also constructed and behaves similarly to pKM201.
Plasmids constructed for this study are described in Table
5 (see Additional file 1).
Primers
The primers used in this study are listed in Table 6 (see
Additional file 2). Those used for the construction of plas-
mids for long homology substrates are named according
to the convention used in reference [3]; U (upstream), N
(N-terminal encoding region), C (C-terminal encoding
region) and D (downstream) of the target gene(s). The
primers used for the construction of PCR-generated (small
homology) substrates are designated as follows: 5KO
(primer sequence anneals to 5' region of target gene(s), 3
KO (primer sequence anneals to 3' region of target
gene(s), H (EHEC), P (EPEC). For EHEC island deletions,
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primer pairs A and B were used to generate PCR recom-
binant fragment with kan reading rightward relative to the
published sequence; primer pairs E and F were used to
generate PCR recombinant fragments with kan reading
leftward relative to the published sequence.
EHEC electroporation and gene replacement protocol
A single fresh colony of EHEC or EPEC was placed into 20
ml of LB plus 15 µg/ml tetracycline (for pTP223) or 100
µg/ml ampicillin (for pKM201 and pKM208) and shaken
at 30°C in an 125 ml flask. At a concentration of ~107
cells/ml, IPTG was added to a final concentration of 1
mM. When the culture reached a density of 0.5 – 1 × 108,
the cells were heat shocked for 15 minutes by swirling at
42°C, transferred to an ice-water bath for 10 min with
swirling, then collected by centrifugation. The cells were
resuspended in 1 ml of ice-cold 20% glycerol - 1 mM
MOPS (unbuffered), transferred to a 1.5 ml sterile eppen-
dorf tube, and spun in a microfuge for 30 seconds (mod-
erate speed). The supernatant was removed; the cells were
resuspended in 1 ml of the same buffer and recentrifuged.
This step was repeated and the cells were finally resus-
pended in 90–100 µl of ice-cold 20% glycerol - 1 mM
MOPS. Electroporation cuvettes (Biorad) were cooled in
an ice-water bath for at least 10 minutes prior to use. DNA
samples contained either 0.1 – 0.5 µg of purified DNA
fragments or 0.2 – 10.0 µg of plasmid digests in TE or
water. A 50 µl sample of cells was mixed with 1–5 µl of
DNA, transferred to the electroporation cuvette, and incu-
bated on ice for 1 minute. The cuvette was thoroughly but
quickly dried and the cells were shocked as described pre-
viously [2]. Following electroporation, the cells were
recovered by suspension in 0.3 ml LB, diluted into 2.7 ml
LB, grown by rolling at 37° for 1.5 hour, and plated on LB
plates containing either 10–15 µg/ml chloramphenicol or
20 µg/ml kanamycin. (Growing for less that one hour
with kanamycin markers drastically reduced the recovery
of recombinants). Alternatively, though usually not
required, the cell cultures were grown overnight before
plating. After overnight growth, drug-resistant transform-
ants of EHEC and EPEC were restreaked on LB plates con-
taining the appropriate drug. In some of the early
experiments, ice-cold water was used instead of 20% glyc-
erol - 1 mM MOPS for resuspending the cells. However,
we found the glycerol/MOPS buffer improved the electro-
poration survivor rate for EHEC (and thus recovery of
recombinants), as was reported for electroporation of
Pseudomonas aeruginosa [38]. In some experiments, trans-
formants were also checked for tetracycline (pTP223) or
ampicillin (pKM201 and pKM208) sensitivity indicating
loss of the Red-producing plasmid (if desired). These Red-
producing plasmids were lost spontaneously at relatively
high frequency following growth and electroporation, i.e.,
selection at 42 degrees for loss of the temp-sensitive
pKM208 replicon was usually not required. Various num-
bers of transformants that successfully restreaked on to
fresh drug plates were analyzed by PCR to verify chromo-
somal replacement of the target gene(s). Gene replace-
ments involving short homology PCR substrates were
verified by using primers outside the region of the chro-
mosome being replaced, while verification of gene
replacements made with plasmid-derived substrates con-
tained one primer outside the flanking homologous
region and the other primer within the drug marker. The
sequence of the primers used for verifying Red-promoted
gene replacements listed in Tables 1, 2, 3 are available
upon request. The selection for SucR-CamS transformants
(containing precise in-frame deletions) was done as
described previously for E. coli K-12 [3].
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